Cargando…

Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus

BACKGROUND: Severe acute respiratory syndrome (SARS) emerged in China in 2002 and spread to other countries before brought under control. Because of a concern for reemergence or a deliberate release of the SARS coronavirus, vaccine development was initiated. Evaluations of an inactivated whole virus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tseng, Chien-Te, Sbrana, Elena, Iwata-Yoshikawa, Naoko, Newman, Patrick C., Garron, Tania, Atmar, Robert L., Peters, Clarence J., Couch, Robert B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335060/ https://www.ncbi.nlm.nih.gov/pubmed/22536382 http://dx.doi.org/10.1371/journal.pone.0035421

Ejemplares similares

Correction: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
por: Tseng, Chien-Te, et al.
Publicado: (2012)

Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
por: Agrawal, Anurodh Shankar, et al.
Publicado: (2016)

TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection
por: Iwata-Yoshikawa, Naoko, et al.
Publicado: (2019)

Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV
por: Lokugamage, Kumari G., et al.
Publicado: (2008)

Immunopathological aspects of coronavirus infections
por: Wege, Helmut
Publicado: (1995)

Glucocorticoid treatment of patients with SARS: implications for mechanisms of immunopathology
por: Panesar, Nirmal S.
Publicado: (2006)

IL-6: Relevance for immunopathology of SARS-CoV-2
por: Gubernatorova, E.O., et al.
Publicado: (2020)

Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
por: Wong, Lok-Yin Roy, et al.
Publicado: (2021)

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology
por: Hemmi, Takuya, et al.
Publicado: (2022)

Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus Infection
por: Yoshikawa, Tomoki, et al.
Publicado: (2010)

STING, a critical contributor to SARS-CoV-2 immunopathology
por: Li, Heyu, et al.
Publicado: (2022)

Tissue immunity to SARS‐CoV‐2: Role in protection and immunopathology
por: Rybkina, Ksenia, et al.
Publicado: (2022)

Surviving the Rookie Virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): The Immunopathology of a SARS-CoV2 Infection
por: Tsai, Sheng Feng, et al.
Publicado: (2021)

Reviewing immunopathology characteristics of SARS-CoV-2 for cancer entwisted with SARS-CoV-2
por: Li, Hongyan, et al.
Publicado: (2021)

Coronavirus vaccine-associated lung immunopathology-what is the significance?
por: Bottazzi, Maria Elena, et al.
Publicado: (2020)

Perspective: Reducing SARS-CoV2 Infectivity and Its Associated Immunopathology
por: Dubey, Abhishek, et al.
Publicado: (2020)

SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings
por: Williams, Phoebe C.M., et al.
Publicado: (2020)

A probable role for IFN-γ in the development of a lung immunopathology in SARS
por: Theron, Michel, et al.
Publicado: (2005)

SARS-CoV-2, Placental Histopathology, Gravity of Infection and Immunopathology: Is There an Association?
por: Resta, Leonardo, et al.
Publicado: (2022)

Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children
por: Buonsenso, Danilo, et al.
Publicado: (2022)

Author Correction: Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
por: Wong, Lok-Yin Roy, et al.
Publicado: (2021)

The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives
por: Boechat, J.L., et al.
Publicado: (2021)

Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China
por: Tan, Mingkai, et al.
Publicado: (2020)

Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection
por: Agrawal, Anurodh Shankar, et al.
Publicado: (2016)

The Immunopathology of COVID-19 and the Cannabis Paradigm
por: Paland, Nicole, et al.
Publicado: (2021)

Schistosomiasis—from immunopathology to vaccines
por: McManus, Donald P., et al.
Publicado: (2020)

Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2
por: Singh, Desh Deepak, et al.
Publicado: (2020)

SARS-CoV-2 pneumonia—receptor binding and lung immunopathology: a narrative review
por: Menezes, Maria Clara Saad, et al.
Publicado: (2021)

Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus
por: Zhang, Naru, et al.
Publicado: (2016)

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
por: Channappanavar, Rudragouda, et al.
Publicado: (2017)

COPD immunopathology
por: Caramori, Gaetano, et al.
Publicado: (2016)

Intranasally administered peptidic viral fusion inhibitor protected hDPP4 transgenic mice from MERS-CoV infection
por: Jiang, Shibo, et al.
Publicado: (2015)

WHO says coronavirus causes SARS
por: Walgate, Robert
Publicado: (2003)

Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus
por: Saijo, Masayuki, et al.
Publicado: (2005)

Road Map to Understanding SARS-CoV-2 Clinico-Immunopathology and COVID-19 Disease Severity
por: Karmakar, Deepmala, et al.
Publicado: (2020)

Gasdermin-D activation by SARS-CoV-2 triggers NET and mediate COVID-19 immunopathology
por: Silva, Camila Meirelles S., et al.
Publicado: (2022)

Correction to: Schistosomiasis—from immunopathology to vaccines
por: McManus, Donald P., et al.
Publicado: (2020)

Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus
por: Devaraj, Santhana G., et al.
Publicado: (2007)

SARS-CoV-2 Vaccination During Pregnancy: A Complex Decision
por: Wang, Elizabeth Wenqian, et al.
Publicado: (2021)

Emergence of SARS-like coronavirus poses new challenge in China
por: Wang, Ruichen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m04d366i08binbcnhf0jvuuh5j